BGAI
XBI icon

Bruce G. Allen Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bruce G. Allen Investments’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30
Closed -$2.79K – 1136
2024
Q2 		$2.79K Hold
30
– – ﹤0.01% 646
2024
Q1 		$2.85K Hold
30
– – ﹤0.01% 666
2023
Q4 		$2.68K Buy
+30
New +$2.23K ﹤0.01% 697

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Bruce G. Allen Investments's XBI Position: Q3 2024 in Review

Bruce G. Allen Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 30 shares — an estimated $2.79K sold.

Bruce G. Allen Investments first reported a position in XBI in Q4 2023 and held it in 3 quarters. The position peaked at $2.85K in Q1 2024. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

  • Bruce G. Allen Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
  • Bruce G. Allen Investments sold 30 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $2.79K.
  • Bruce G. Allen Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 3 quarters.
  • Bruce G. Allen Investments's State Street SPDR S&P Biotech ETF position peaked at $2.85K in Q1 2024.
  • 769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Bruce G. Allen Investments's 13F filing for Q3 2024, filed 8 Oct 2024.